ロード中...
The Evolving Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Treatment
Hepatocellular carcinoma (HCC) is one of most common cancers and the fourth leading cause of death worldwide. Commonly, HCC development occurs in a liver that is severely compromised by chronic injury or inflammation. Liver transplantation, hepatic resection, radiofrequency ablation (RFA), transcath...
保存先:
| 出版年: | Vaccines (Basel) |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8160723/ https://ncbi.nlm.nih.gov/pubmed/34065489 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines9050532 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|